Managing Skeletal-Related Events in Multiple Myeloma Patients
- Burgess L. Preventing skeletal-related events in patients with solid tumors. Bone Cancer Advisor. Published August 13, 2013. https://www.cancertherapyadvisor.com/bone-cancer/preventing-skeletal-related-events-in-patients-with-solid-tumors/article/307221/ Accessed June 25, 2018.
- Terpos E, Ntansis-Stathopoulos I, Gavriatopoulou M, Dimopoulos MA. Pathogenesis of bone disease in multiple myeloma: From bench to bedside. Blood Cancer Journal. 2018; 8 (7). https://www.nature.com/articles/s41408-017-0037-4 Accessed June 25, 2018.
- Chemocare. Xgeva. http://chemocare.com/chemotherapy/drug-info/Xgeva.aspx Accessed June 25, 2018.
- Broderick JM. FDA Approves Denosumab for Multiple Myeloma. OncLive. https://www.onclive.com/web-exclusives/fda-approves-denosumab-for-multiple-myeloma. Accessed June 26, 2018.